Nicotinamide boosts oocyte quantity and quality by promoting N4-acetylation modification in lupus mice

Yun Xie1,2,3, Chuanchuan Zhou1,2,3, Qi Guo1,2,3

  • 1Reproductive Medicine Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China.

Science Advances
|July 18, 2025
PubMed

Insights

Systemic lupus erythematosus (SLE) disrupts oocyte development by impairing protein translation linked to N4-acetylcytidine (ac4C) modification. Nicotinamide treatment safely enhances ac4C levels, improving oocyte quality and quantity in SLE mice.

Area of Science:

  • Reproductive Biology
  • Molecular Biology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is associated with reduced fertility in patients.
  • Oocyte development and meiosis rely heavily on precise gene translation.
  • The impact of SLE on oocyte gene translation remains largely unknown.

Purpose of the Study:

  • To investigate the effects of SLE on gene translation in oocytes.
  • To identify molecular mechanisms underlying SLE-induced oocyte dysfunction.
  • To explore potential therapeutic strategies for improving fertility in SLE.

Main Methods:

  • Single-cell transcriptome and translatome sequencing in SLE mouse models.
  • In vitro experiments assessing the role of N4-acetylcytidine (ac4C) modification.
  • Trace-cell ac4C-RNA immunoprecipitation (acRIP) sequencing.
  • Assessment of nicotinamide treatment effects on oocyte quantity and quality.

Main Results:

  • SLE significantly disrupts protein translation in oocytes, linked to ac4C modification.
  • Reduced ac4C levels impair oocyte translation efficiency, notably affecting Zygote arrest 1.
  • Nicotinamide treatment enhanced ac4C levels, improving oocyte quantity and quality in SLE mice.
  • N-acetyltransferase 10 (NAT10) plays a key role in ac4C-mediated oocyte development.

Conclusions:

  • ac4C modification is crucial for normal oocyte development in the context of SLE.
  • Dysfunctional ac4C modification contributes to impaired oocyte quality in SLE.
  • Nicotinamide shows promise as a safe therapeutic agent to improve fertility in SLE patients.